Trial Profile

Phase III trial of Minocycline topical Gel (HY01) in patients with Papulopustular Rosacea

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 24 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Minocycline (Primary)
Indications Rosacea
Focus Therapeutic Use
Acronyms MARS-3

Most Recent Events

24 Sep 2019 New trial record
20 Sep 2019 According to a Hovione media release, the company anticipates initiating this trial subject to entering into a strategic collaboration with a commercial partner by fourth quarter of 2 aiming at filing the NDA during 2021.
20 Sep 2019 According to a Hovione media release, the company received guidance for the design and clinical endpoints for HY01 at a recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com